← Back to Search

Other

GAL1906 for Wrinkles

N/A
Waitlist Available
Research Sponsored by Q-Med AB
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks after initial injection
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new treatment called GAL1906 to see if it can safely and effectively reduce wrinkles in the upper chest area. It focuses on people who want to improve the appearance of their skin in that region.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks after initial injection
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks after initial injection for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
The percentage of responders on the Galderma Décolletage Scale, as assessed live by the Blinded Evaluator, at Week 12.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: GAL1906Experimental Treatment1 Intervention
Experimental product for correction of wrinkles
Group II: ControlActive Control1 Intervention
No treatment control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GAL1906
2021
N/A
~200

Find a Location

Who is running the clinical trial?

Q-Med ABLead Sponsor
80 Previous Clinical Trials
12,485 Total Patients Enrolled
1 Trials studying Wrinkles
110 Patients Enrolled for Wrinkles
Galderma R&DLead Sponsor
302 Previous Clinical Trials
60,495 Total Patients Enrolled
8 Trials studying Wrinkles
1,156 Patients Enrolled for Wrinkles

Media Library

GAL1906 (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04717934 — N/A
Wrinkles Research Study Groups: GAL1906, Control
Wrinkles Clinical Trial 2023: GAL1906 Highlights & Side Effects. Trial Name: NCT04717934 — N/A
GAL1906 (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04717934 — N/A
Wrinkles Patient Testimony for trial: Trial Name: NCT04717934 — N/A
~40 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top